If you or a loved one has been diagnosed with pancreatic cancer, we can help you understand the disease and your options. PanCAN Patient Services Case Managers are available to support you and connect ...

PanCAN welcomes Jon Mahrt, Chief Executive Officer of Optum Rx and Chief Growth Officer of Optum to the Board of Directors. In this Q&A, Jon shares his personal connection to the cause, his passion ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

We're the national organization providing support, resources, volunteer opportunities and hope for people fighting pancreatic cancer.

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Makes: 1 16 oz smoothie By: Tuesday Hoelscher, RDN Ingredients: 1/2 c Boost High Protein 1/2 c full fat Greek yogurt 2 tbsp chia seeds 1/2 c spinach 1/2 c mango 1 c blueberries 1/2 c orange juice ...

PanCAN answers questions that came in during our Pancreatic Cancer Clinical Trials Awareness Month webinar.

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit outlines the latest advances in pancreatic cancer and offers key insights from ASCO GI 2025.

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...

The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit attended the 5th RAS Initiative Symposium, hearing about RAS-targeted therapies and breakthroughs that may benefit patients with ...

Anna Berkenblit, MD, MMSc, is looking forward to bringing her dual experience as a clinician and biotech executive to her new role as PanCAN’s Chief Scientific and Medical Officer.